ARTICLE | Top Story
AstraZeneca to acquire Pearl for up to $1.2B
June 11, 2013 1:36 AM UTC
AstraZeneca plc (LSE:AZN; NYSE:AZN) will acquire Pearl Therapeutics Inc. (Redwood City, Calif.) for $560 million up front. Pearl will be eligible for up to $450 million in development and regulatory m...